Sonoma Pharmaceuticals, Inc. (NASDAQ: SNOA) reported Q4 EPS of ($0.29), $0.17 worse than the analyst estimate of ($0.12). Revenue for the quarter came in at $3.4 million versus the consensus estimate of $3.38 million.

For earnings history and earnings-related data on Sonoma Pharmaceuticals, Inc. (SNOA) click here.